AbbVie to buy Botox-maker Allergan in $63 billion deal AbbVie said today it would buy Botox-maker Allergan in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics … Business • 25 Jun 19
